RxDoctor Payments Data

Shawn Braunagel, DPM

Podiatrist · Billings, MTNPI 1154766079

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (38.6%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Kerecis Limited at 46.5% of the total.

$33,772in general payments, 2019–2025

Across 220 payments — averaging $153.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kerecis Limited$16K
  • Integra Lifesciences Corporation$12K
  • Ossio Inc$4K
  • Smith+Nephew$1K
  • GSK$123
  • Amgen$87
  • plus $440 from 11 others

What the payments were for

  • Consulting fees$13,04239%
  • Speaking & faculty fees$9,27527%
  • Travel & lodging$6,10118%
  • Food & beverage$3,97912%
  • Education$7502%
  • Other$6252%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few podiatrist providers in Montanato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$258,248
Medicare patients
952
Services billed
5,212

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox38$743
Terbinafine Hcl95$724
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip25$484
Gentamicin Sulfate12$483
Doxycycline Hyclate50$354
Cephalexin28$184
Oxycodone Hcl52$180
Methylprednisolone18$116

Paid to pharmacies, not to this prescriber.

Other podiatrist in Billings

See the full list for Montana

Where these figures come from

Is this you, or does something look wrong? →